CN Patent

CN102630160B — 透皮递送系统、其制备方法以及使用所述系统的透皮递送方法

Assigned to Sanyang Holding Co · Expires 2014-05-07 · 12y expired

What this patent protects

本申请公开了具有多粘胶层的透皮递送系统，其具有作为控制药物递送速率的中间层的不含药物的粘胶层。所述透皮递送系统在施用于皮肤后的早期提高透皮递送速率并且在中期和后期提供对药物递送速率的持久控制。因此，能够以持久的方式控制对治疗有效的药物递送速率。

USPTO Abstract

本申请公开了具有多粘胶层的透皮递送系统，其具有作为控制药物递送速率的中间层的不含药物的粘胶层。所述透皮递送系统在施用于皮肤后的早期提高透皮递送速率并且在中期和后期提供对药物递送速率的持久控制。因此，能够以持久的方式控制对治疗有效的药物递送速率。

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: CN102630160B
Jurisdiction: CN
Classification: —
Expires: 2014-05-07
Drug substance claim: No
Drug product claim: No
Assignee: Sanyang Holding Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.